BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16951171)

  • 1. Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma.
    Kouvaraki MA; Korapati AL; Rassidakis GZ; Tian L; Zhang Q; Chiao P; Ho L; Evans DB; Claret FX
    Cancer Res; 2006 Sep; 66(17):8581-9. PubMed ID: 16951171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.
    Sorbye SW; Kilvaer TK; Valkov A; Donnem T; Smeland E; Al-Shibli K; Bremnes RM; Busund LT
    PLoS One; 2012; 7(10):e47068. PubMed ID: 23071715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jab1 as a mediator of nuclear export and cytoplasmic degradation of p53.
    Lee EW; Oh W; Song J
    Mol Cells; 2006 Oct; 22(2):133-40. PubMed ID: 17085963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer analyses of Jab1/COPS5 reveal oncogenic role and clinical outcome in human cancer.
    Wang L; Zeng X; Yang G; Liu G; Pan Y
    Heliyon; 2022 Dec; 8(12):e12553. PubMed ID: 36643321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of posttranslational modifications in pancreatic carcinogenesis and treatments.
    Chen N; Zheng Q; Wan G; Guo F; Zeng X; Shi P
    Cancer Metastasis Rev; 2021 Sep; 40(3):739-759. PubMed ID: 34342796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a seven-long non-coding RNA signature associated with Jab1/CSN5 in predicting hepatocellular carcinoma.
    Ma W; Yao Y; Xu G; Wu X; Li J; Wang G; Chen X; Wang K; Chen Y; Guo Y; Li Y; Tan D; Guo H; Liu Z; Yuan Y; Claret FX
    Cell Death Discov; 2021 Jul; 7(1):178. PubMed ID: 34247194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1.
    Chen H; Padia R; Li T; Li Y; Li B; Jin L; Huang S
    NPJ Breast Cancer; 2021 Jul; 7(1):91. PubMed ID: 34244488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Antioxidant Enzyme Methionine Sulfoxide Reductase A (MsrA) Interacts with Jab1/CSN5 and Regulates Its Function.
    Jiang B; Adams Z; Moonah S; Shi H; Maupin-Furlow J; Moskovitz J
    Antioxidants (Basel); 2020 May; 9(5):. PubMed ID: 32456285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COP9 signalosome subunit 5 regulates cancer metastasis by deubiquitinating SNAIL.
    Watanabe K; Yokoyama S; Kaneto N; Hori T; Iwakami Y; Kato S; Hayakawa Y; Sakurai H; Fukuoka J; Saiki I
    Oncotarget; 2018 Apr; 9(29):20670-20680. PubMed ID: 29755680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer.
    Liu G; Claret FX; Zhou F; Pan Y
    Front Pharmacol; 2018; 9():135. PubMed ID: 29535627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revealing protein networks and gene-drug connectivity in cancer from direct information.
    Jiang XL; Martinez-Ledesma E; Morcos F
    Sci Rep; 2017 Jun; 7(1):3739. PubMed ID: 28623316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rottlerin exhibits anti-cancer effect through inactivation of S phase kinase-associated protein 2 in pancreatic cancer cells.
    Su J; Wang L; Yin X; Zhao Z; Hou Y; Ye X; Zhou X; Wang Z
    Am J Cancer Res; 2016; 6(10):2178-2191. PubMed ID: 27822410
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Wang C; Feng Z; Jiang K; Zuo X
    Oncol Res; 2017 Apr; 25(4):559-569. PubMed ID: 27733216
    [No Abstract]   [Full Text] [Related]  

  • 14. Associations and prognostic significance of p27
    Ma Y; Yan M; Huang H; Zhang L; Wang Q; Zhao Y; Zhao J
    Mol Clin Oncol; 2016 Oct; 5(4):357-364. PubMed ID: 27703676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway.
    Zhu Y; Qiu Z; Zhang X; Qian F; Wang B; Wang L; Shi H; Yu R
    J Neurooncol; 2017 Jan; 131(1):31-39. PubMed ID: 27640199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.
    Pan Y; Wang S; Su B; Zhou F; Zhang R; Xu T; Zhang R; Leventaki V; Drakos E; Liu W; Claret FX
    Oncogene; 2017 Feb; 36(8):1069-1079. PubMed ID: 27524414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging roles of Jab1/CSN5 in cancer.
    Wang L; Zheng JN; Pei DS
    Med Oncol; 2016 Aug; 33(8):90. PubMed ID: 27412572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
    Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX
    Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of the COP9 Signalosome and Neddylation in DNA Damage Signaling and Repair.
    Chung D; Dellaire G
    Biomolecules; 2015 Sep; 5(4):2388-416. PubMed ID: 26437438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma.
    Chen W; Hu GH
    Cancer Biol Med; 2015 Mar; 12(1):23-32. PubMed ID: 25859408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.